Company / EPS (Diluted)
PUMA BIOTECHNOLOGY, INC. EPS (Diluted) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.45
FY2025
5-year range
-$1.52 / $0.45
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has increased for 3 consecutive years, from $-1.52 in FY2022 to $0.45 in FY2025.
Based on SEC 10-K filings.
0.45 in FY2025.
Improved from $-0.72 to $0.45 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Lowest eps (diluted) in the period was in FY2018.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.45 | - |
| FY2024 | $0.00 | +100.0% |
| FY2023 | -$0.72 | +52.6% |
| FY2022 | -$1.52 | - |
| FY2021 | - | - |
| FY2020 | -$0.43 | +94.5% |
| FY2019 | -$7.85 | +5.3% |
| FY2018 | -$8.29 | -11.3% |
| FY2017 | -$7.45 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026